These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 20334889)

  • 21. Genetic Variability of Myxoma Virus Genomes.
    Braun C; Thürmer A; Daniel R; Schultz AK; Bulla I; Schirrmeier H; Mayer D; Neubert A; Czerny CP
    J Virol; 2017 Feb; 91(4):. PubMed ID: 27903800
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Entry and Disassembly of Large DNA Viruses: Electron Microscopy Leads the Way.
    Quemin ER; Corroyer-Dulmont S; Krijnse-Locker J
    J Mol Biol; 2018 Jun; 430(12):1714-1724. PubMed ID: 29702107
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification from diverse mammalian poxviruses of host-range regulatory genes functioning equivalently to vaccinia virus C7L.
    Meng X; Chao J; Xiang Y
    Virology; 2008 Mar; 372(2):372-83. PubMed ID: 18054061
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro screen of a small molecule inhibitor drug library identifies multiple compounds that synergize with oncolytic myxoma virus against human brain tumor-initiating cells.
    McKenzie BA; Zemp FJ; Pisklakova A; Narendran A; McFadden G; Lun X; Kenchappa RS; Kurz EU; Forsyth PA
    Neuro Oncol; 2015 Aug; 17(8):1086-94. PubMed ID: 25605818
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TRAF2 facilitates vaccinia virus replication by promoting rapid virus entry.
    Haga IR; Pechenick Jowers T; Griffiths SJ; Haas J; Beard PM
    J Virol; 2014 Apr; 88(7):3664-77. PubMed ID: 24429366
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Myxoma virus protein M029 is a dual function immunomodulator that inhibits PKR and also conscripts RHA/DHX9 to promote expanded host tropism and viral replication.
    Rahman MM; Liu J; Chan WM; Rothenburg S; McFadden G
    PLoS Pathog; 2013; 9(7):e1003465. PubMed ID: 23853588
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacological manipulation of the akt signaling pathway regulates myxoma virus replication and tropism in human cancer cells.
    Werden SJ; McFadden G
    J Virol; 2010 Apr; 84(7):3287-302. PubMed ID: 20106927
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Orthopoxvirus species and strain differences in cell entry.
    Bengali Z; Satheshkumar PS; Moss B
    Virology; 2012 Nov; 433(2):506-12. PubMed ID: 22999097
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drosophila S2 cells are non-permissive for vaccinia virus DNA replication following entry via low pH-dependent endocytosis and early transcription.
    Bengali Z; Satheshkumar PS; Yang Z; Weisberg AS; Paran N; Moss B
    PLoS One; 2011 Feb; 6(2):e17248. PubMed ID: 21347205
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Myxoma virus infection promotes NK lysis of malignant gliomas in vitro and in vivo.
    Ogbomo H; Zemp FJ; Lun X; Zhang J; Stack D; Rahman MM; McFadden G; Mody CH; Forsyth PA
    PLoS One; 2013; 8(6):e66825. PubMed ID: 23762498
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myxoma virus and oncolytic virotherapy: a new biologic weapon in the war against cancer.
    Stanford MM; McFadden G
    Expert Opin Biol Ther; 2007 Sep; 7(9):1415-25. PubMed ID: 17727330
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ex vivo virotherapy with myxoma virus does not impair hematopoietic stem and progenitor cells.
    Villa NY; Bais S; Chan WM; Meacham AM; Wise E; Rahman MM; Moreb JS; Rosenau EH; Wingard JR; McFadden G; Cogle CR
    Cytotherapy; 2016 Mar; 18(3):465-80. PubMed ID: 26857235
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recombinant Myxoma Virus Expressing Walleye Dermal Sarcoma Virus orfC Is Attenuated in Rabbits.
    Ashton LV; Quackenbush SL; Castle J; Wilson G; McCoy J; Jordan M; MacNeill AL
    Viruses; 2020 May; 12(5):. PubMed ID: 32397134
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Vaccinia Virus (VACV) B1 and Cellular VRK2 Kinases Promote VACV Replication Factory Formation through Phosphorylation-Dependent Inhibition of VACV B12.
    Rico AB; Wang Z; Olson AT; Linville AC; Bullard BL; Weaver EA; Jones C; Wiebe MS
    J Virol; 2019 Oct; 93(20):. PubMed ID: 31341052
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vaccinia virus strains use distinct forms of macropinocytosis for host-cell entry.
    Mercer J; Knébel S; Schmidt FI; Crouse J; Burkard C; Helenius A
    Proc Natl Acad Sci U S A; 2010 May; 107(20):9346-51. PubMed ID: 20439710
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oncolytic Virotherapy with Myxoma Virus.
    Rahman MM; McFadden G
    J Clin Med; 2020 Jan; 9(1):. PubMed ID: 31936317
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oncolytic myxoma virus: the path to clinic.
    Chan WM; Rahman MM; McFadden G
    Vaccine; 2013 Sep; 31(39):4252-8. PubMed ID: 23726825
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiviral activities of two nucleos(t)ide analogs against vaccinia, mpox, and cowpox viruses in primary human fibroblasts.
    Dsouza L; Pant A; Offei S; Priyamvada L; Pope B; Satheshkumar PS; Wang Z; Yang Z
    Antiviral Res; 2023 Aug; 216():105651. PubMed ID: 37270160
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Myxoma Virus-Encoded Host Range Protein M029: A Multifunctional Antagonist Targeting Multiple Host Antiviral and Innate Immune Pathways.
    Rahman MM; McFadden G
    Vaccines (Basel); 2020 May; 8(2):. PubMed ID: 32456120
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Colonization of xenograft tumors by oncolytic vaccinia virus (VACV) results in enhanced tumor killing due to the involvement of myeloid cells.
    Kilinc MO; Ehrig K; Pessian M; Minev BR; Szalay AA
    J Transl Med; 2016 Dec; 14(1):340. PubMed ID: 27993141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.